Ribavirin Quantification in Combination Treatment of Chronic Hepatitis C

Ribavirin in combination with alpha 2 interferon is the consensus treatment for chronic hepatitis C. However, recent preliminary pharmacological studies have suggested that the bioavailability of ribavirin displays great interindividual variability. In order to monitor serum ribavirin levels during...

詳細記述

書誌詳細

出版年:	Antimicrob Agents Chemother
主要な著者:	Larrat, Sylvie, Stanke-Labesque, Françoise, Plages, Agnès, Zarski, Jean-Pierre, Bessard, Germain, Souvignet, Claude
フォーマット:	Artigo
言語:	Inglês
出版事項:	American Society for Microbiology (ASM) 2003
主題:	Antiviral Agents
オンライン･アクセス:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC149002/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12499179/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.1.124-129.2003
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!